Stock & Company Details
Ensysce Biosciences Inc $ENSC
Price:
46,691,331
15M
$4.5M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.28
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ENSC technical indicators
Latest Ensysce Biosciences Inc (ENSC) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
49.15 6.8%
MACD:
-0.01 14.5%
SMA 50:
$0.32 1.3%
SMA 200:
$1.04 0.9%
EMA 20:
$0.28 0.2%
Bollinger Bands:
0.31 / 0.24
Stochastic:
62.96 11.5%
ADX 14:
20.48 5.6%
ATR 14:
0.03 4.8%
CCI 20:
115.06 29.5%
OBV:
558.70M 0.1%
ROC 12:
11.54% 42.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform.
Finance Bot
Ask your questions
Start by typing a question below.
